Buell Jennifer 4
Research Summary
AI-generated summary
Agenus (AGEN) Director Jennifer Buell Receives Stock Award
What Happened
- Jennifer Buell, Chairman of the Executive Counsel at Agenus (AGEN), was granted option awards covering 300,000 and 5,000 shares (total 305,000) on April 24, 2026. The filing reports these as derivative awards with a reported per-share amount of $0.00 (total $0 in immediate cash consideration). The award is made under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.
Key Details
- Transaction date: 2026-04-24; Form 4 filed: 2026-04-28.
- Securities: two derivative awards (options) — 300,000 and 5,000 shares; total 305,000.
- Reported price/value on Form 4: $0.00 per share (reported $0 total for acquisition).
- Vesting: vests over three years — one-third vests on April 24, 2027, remainder vests in equal quarterly installments thereafter (per footnote).
- Shares owned after transaction: not disclosed in the Form 4.
- Transaction type: Award/Grant (code A). Filing shows no indication of a late filing.
Context
- These are option grants (derivative securities) as part of compensation under the company equity plan, not an open-market purchase or sale. Such grants are routine for executives and provide the right to acquire shares in the future subject to vesting; they do not necessarily signal an immediate change in insider sentiment.